Authors

• Peng Gong (ORCID: https://orcid.org/0000-0001-9568-0296)
• Yongcheng Su (ORCID: https://orcid.org/0000-0001-6322-7681)
• Xianbin Zhang (ORCID: https://orcid.org/0000-0002-0948-6698)
• Pingping Zhang (ORCID: https://orcid.org/0000-0002-5315-1270)
• Xu Beibei
• Jiahui Yuan (ORCID: https://orcid.org/0000-0002-8476-2832)

Institutions

• Second Military Medical University (CN)
• Xiamen University (CN)
• Chinese Academy of Sciences (CN)
• Changhai Hospital (CN)
• Chinese University of Hong Kong, Shenzhen (CN)
• Shenzhen Institutes of Advanced Technology (CN)

Publication Details

Journal

BMC Cancer

Published

2025-04-22

DOI

https://doi.org/10.1186/s12885-025-14096-x

Citations

2

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

2.09

Funders

• National Natural Science Foundation of China
• Science, Technology and Innovation Commission of Shenzhen Municipality